Amifampridine Phosphate
MSK-003
Phase 3 small_molecule terminated
Quick answer
Amifampridine Phosphate for Myasthenia Gravis, MuSK is a Phase 3 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Myasthenia Gravis, MuSK
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated